Topic 281 phase i sbir

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201000126C
Awardee
Awarding agency
Obligated
$150,000

Award facts

Contract value 100% obligated
$150,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Boulder, CO 80301, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 2 · Topic 281 phase i sbir - change-of-name $0
Other Administrative Action 1 $0
Original award $150,000

About this award

This is a $150,000 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Bioptix Diagnostics, Inc., a for-profit manufacturer. The contract is for Phase I of a Small Business Innovation Research (SBIR) project under Topic 281. The contract has a completion date of June 29, 2011. As an SBIR award, this contract was set aside for small businesses.

Quick answers

Who was awarded contract HHSN261201000126C?

HHSN261201000126C was awarded to Bioptix Diagnostics, Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2010.

How much is contract HHSN261201000126C worth?

The government has obligated $150,000 on HHSN261201000126C.

Was contract HHSN261201000126C competed?

The extent of competition for HHSN261201000126C was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award